Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

H. R. Mali; S. A. Siddiqui; Madhur Garg; R. K. Singh; M. L.B. Bhatt

doi:10.1007/BF02873441

Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

H. R. Mali, S. A. Siddiqui, Madhur Garg, R. K. Singh, M. L.B. Bhatt

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

Original language	English (US)
Pages (from-to)	36-40
Number of pages	5
Journal	Indian Journal of Clinical Biochemistry
Volume	13
Issue number	1
DOIs	https://doi.org/10.1007/BF02873441
State	Published - 1998
Externally published	Yes

Keywords

Malignancy
Radiotherapy
Serum copper

ASJC Scopus subject areas

Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF02873441

Cite this

@article{7ce36950a27e46c0bfb2e22e00fbb094,

title = "Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy",

abstract = "Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.",

keywords = "Malignancy, Radiotherapy, Serum copper",

author = "Mali, {H. R.} and Siddiqui, {S. A.} and Madhur Garg and Singh, {R. K.} and Bhatt, {M. L.B.}",

year = "1998",

doi = "10.1007/BF02873441",

language = "English (US)",

volume = "13",

pages = "36--40",

journal = "Indian Journal of Clinical Biochemistry",

issn = "0970-1915",

publisher = "Springer India",

number = "1",

}

TY - JOUR

T1 - Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

AU - Mali, H. R.

AU - Siddiqui, S. A.

AU - Garg, Madhur

AU - Singh, R. K.

AU - Bhatt, M. L.B.

PY - 1998

Y1 - 1998

N2 - Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

AB - Present study reports changes in serum copper levels (SCL) in various neoplastic diseases undergoing radiotherapy. We estimated SCLs in 140 individuals comprising of 90 previously untreated patients with various malignancies and 50 healthy controls. Patients received radiation in doses of 40-70 Gy in 4-7 weeks. SCLs were again estimated in patients following irradiation, the mean SCL was significantly higher (P<0.001) in cancer patients as compared to healthy controls. It declined significantly (P<0.001) following irradiation. However, it remained significantly higher as compared to healthy controls (P<0.01). Highest fall in SCL was seen in complete clinical responders and least in non-responders to radiation treatment. Serial estimation of SCLs may be useful in the treatment monitoring of the neoplasms undergoing radiation treatment.

KW - Malignancy

KW - Radiotherapy

KW - Serum copper

UR - http://www.scopus.com/inward/record.url?scp=77950096797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950096797&partnerID=8YFLogxK

U2 - 10.1007/BF02873441

DO - 10.1007/BF02873441

M3 - Article

AN - SCOPUS:77950096797

VL - 13

SP - 36

EP - 40

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -

Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this